Clarivate (NYSE: CLVT) insider now holds 147,255 shares

Rhea-AI Filing Summary

CLARIVATE PLC (CLVT) reported that a senior officer received an equity award. On 2026-08-15, the Senior VP and CAO, as the reporting person, was granted 67,357 Ordinary Shares at a price of $0.00 per share as a grant or award acquisition. Following this award, the reporting person directly holds 147,255 Ordinary Shares.

Insider Trade Summary

Net Buyer: 67,357 shares

Net Buy 1 txn

Insider Lisowski Matthew J.

Role Senior VP, CAO

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	67,357	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 147,255 shares (Direct)

Key Figures

Shares Granted: 67,357 Ordinary Shares Grant Price: $0.00 per share Shares Held After Grant: 147,255 Ordinary Shares

3 metrics

Shares Granted 67,357 Ordinary Shares Equity grant to Senior VP, CAO on 2026-08-15

Grant Price $0.00 per share Price for the 67,357-share award on 2026-08-15

Shares Held After Grant 147,255 Ordinary Shares Direct holdings of the reporting officer following the transaction

Key Terms

Grant, award, or other acquisition, Ordinary Shares, Senior VP, CAO

3 terms

Grant, award, or other acquisition financial

"transaction code description is "Grant, award, or other acquisition""

Ordinary Shares financial

"security_title listed as "Ordinary Shares" in the transaction"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Senior VP, CAO other

"reporting person’s officer_title is "Senior VP, CAO""

FAQ

What insider transaction did CLVT report for Matthew J. Lisowski?

CLVT reported that its Senior VP and CAO, Matthew J. Lisowski, received a grant of 67,357 Ordinary Shares on 2026-08-15. The shares were awarded at $0.00 per share, reflecting a compensation-related equity award rather than an open-market purchase.

How many CLVT shares does the reporting officer hold after this Form 4 transaction?

After the reported grant, the officer directly holds 147,255 Ordinary Shares of CLVT. This total includes the newly awarded 67,357 shares, indicating an increased direct equity position in Clarivate PLC through compensation-related stock awards.

Was the CLVT insider transaction on 2026-08-15 a purchase or an award?

The 2026-08-15 transaction was classified as a grant, award, or other acquisition of CLVT shares, not a market purchase. The $0.00 per share price confirms the shares were received as compensation rather than bought on the open market.

Did Clarivate’s Senior VP, CAO sell any CLVT shares in this Form 4?

No sales were reported; the Form 4 shows only an acquisition of 67,357 Ordinary Shares via grant. Post-transaction, the reporting officer’s direct holdings increased to 147,255 shares, with no concurrent dispositions disclosed in this filing.

Was the CLVT insider grant made under a Rule 10b5-1 trading plan?

The document-level indicator shows the Rule 10b5-1 checkbox was not marked for this CLVT Form 4. The reported 67,357-share grant to the Senior VP and CAO is therefore not identified as executed under a 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/18/2026 - 05:09 PM Accepted by SEC EDGAR 08/18/2026 - 05:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lisowski Matthew J.

(Last) (First) (Middle)

C/O CLARIVATE PLC

70 ST. MARY AXE

(Street)

LONDON EC3A 8BE

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
CLARIVATE PLC [ CLVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP, CAO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/15/2026		A		67,357	A	$0	147,255	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ John Doulamis, Attorney-in-Fact	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)